Peritoneal cancer Market | Size, Share, Growth

Peritoneal cancer Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - March

Report Code: VMR-18331

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Peritoneal cancer Market (2025-2030)

Peritoneal cancer is a rare but aggressive malignancy originating in the peritoneum, the thin layer of tissue lining the abdomen. It shares histological and clinical similarities with ovarian cancer, often leading to late-stage diagnoses and limited treatment options. Advances in molecular profiling, immunotherapy, and precision medicine are reshaping therapeutic landscapes, improving patient outcomes through targeted interventions and innovative drug combinations.

Disruptive Impact and Opportunities:
The market is witnessing transformative changes driven by novel antibody-drug conjugates, next-generation immunotherapies, and innovative targeted therapies. These advancements enable earlier detection and more effective treatment strategies, addressing an unmet need in a traditionally challenging oncology segment. Emerging therapeutics such as Luvelta (STRO-002), IMGN151, and Catumaxomab offer groundbreaking approaches that improve safety profiles and therapeutic efficacy. The integration of AI-driven diagnostics and biomarker-driven therapies streamlines treatment decision-making, making personalized medicine more accessible.

Emerging Drugs:

Luvelta (STRO-002)
IMGN151
Catumaxomab

Marketed Drugs:

Zejula
Avastin
Bevacizumab
Niraparib
Mvasi
Elahere
Alymsys

Key Companies:

Shattuck Labs, Inc.
Corcept Therapeutics
Seagen
Mersana Therapeutics
IMPACT Therapeutics
ImmunoGen
LintonPharm Co., Ltd.
Sutro Biopharma, Inc.
Elucida Oncology
Bio-Path Holdings
Clover Biopharmaceutical AUS Pty Ltd
Rhizen Pharmaceuticals SA
Oncoinvent
OncoMed Pharmaceuticals, Inc.
Ipsen
Green3Bio

Market Segmentation:

By Type

Primary Peritoneal Cancer
Secondary Peritoneal Cancer
- Peritoneal Carcinomatosis
- Peritoneal Mesothelioma
- Peritoneal Sarcomatosis

By Administration Type

Oral
Intravenous (IV)
Intraperitoneal (IP)
Subcutaneous (SC)

What’s in It for You?

Comprehensive insights into emerging and marketed therapeutics
Strategic analysis of competitive dynamics and key market players
Evaluation of novel treatment modalities and clinical advancements
Identification of investment opportunities in breakthrough oncology innovations
Data-driven recommendations for informed decision-making in R&D and commercialization

Peritoneal Cancer Market- Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2022 & 2032: By Key Country (10MM)
  2. Global Market Size 2022 & 2032: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900